HEALTH REFORM: The Drug Industry’s Sweetheart Deal

It turns out that spending $609,000 a day on lobbying can be a great investment. Health reform is looking to be very, very good for the pharmaceutical business. Jon Cohn has new evidence on why we should take their complaints about the bill with two aspirin–and a grain of salt.